80 related articles for article (PubMed ID: 6170430)
1. Chemotherapeutic trials with hamster mesothelioma 10-24: responses to azacitidine, aziridinylbenzoquinone, cisplatin, and PCNU.
Holiat SM; Smith WE; Hubert DD; Davis S
Cancer Treat Rep; 1981; 65(11-12):1113-5. PubMed ID: 6170430
[TBL] [Abstract][Full Text] [Related]
2. Complete remissions in chemotherapy of lung cancer models induced in mice by asbestos.
Smith WE; Hubert DD; Yazdi E; Holiat SM; Bissell EC; Watts LM; Baylouny RA; Sobel HJ
Mt Sinai J Med; 2005 Jan; 72(1):23-32. PubMed ID: 15682259
[TBL] [Abstract][Full Text] [Related]
3. Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzoquinone, and cis-platinum.
Schold SC; Rawlings CE; Bigner SH; Bigner DD
Neurosurgery; 1983 Jun; 12(6):672-7. PubMed ID: 6683794
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of aziridinylbenzoquinone administered Iv to beagle dogs.
Hacker MP; Hong CB; McKee MJ; Unwin SE; Urbanek MA
Cancer Treat Rep; 1982 Oct; 66(10):1845-51. PubMed ID: 7127322
[No Abstract] [Full Text] [Related]
5. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
Rubin J; van Hazel GA; Schutt AJ; Moertel CG; O'Connell MJ
Am J Clin Oncol; 1982 Oct; 5(5):539-40. PubMed ID: 7180832
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of aziridinylbenzoquinone in refractory lymphoma.
Case DC; Hayes DM
Cancer Treat Rep; 1983 Nov; 67(11):993-6. PubMed ID: 6357437
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
Tan CT; Hancock CH; Mondora A; Hoffman NW
Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
[TBL] [Abstract][Full Text] [Related]
8. Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line.
Da Silva VF; Raaphorst GP; Goyal R; Feeley M
J Neurosurg; 1987 Dec; 67(6):885-8. PubMed ID: 3681426
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma.
Creagan ET; Schutt AJ; Ahmann DL; Green SJ
Cancer Treat Rep; 1982 Dec; 66(12):2089-90. PubMed ID: 7139650
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of diaziquone in malignant mesothelioma.
Eagan RT; Frytak S; Richardson RL; Creagan ET; Nichols WC
Cancer Treat Rep; 1986 Mar; 70(3):429. PubMed ID: 3955559
[No Abstract] [Full Text] [Related]
11. AZQ therapy in patients with disseminated malignant melanoma.
Yap BS; Bedikian AY; Burgess MA; Bodey GP
Am J Clin Oncol; 1982 Dec; 5(6):623-5. PubMed ID: 7165003
[TBL] [Abstract][Full Text] [Related]
12. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
Tannock I
Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436
[TBL] [Abstract][Full Text] [Related]
13. Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.
Johnson RK; Wodinsky I; Swiniarski J; Meaney KF; Clement JJ
Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1605-9. PubMed ID: 583418
[No Abstract] [Full Text] [Related]
14. A phase I trial of aziridinylbenzoquinone (NSC 192986) in patients with previously treated acute leukemia.
Van Echo DA; Schulman P; Budman DR; Ferrari A; Wiernik PH
Am J Clin Oncol; 1982 Aug; 5(4):405-10. PubMed ID: 7113963
[TBL] [Abstract][Full Text] [Related]
15. Experimental combination chemotherapy: intracarotid versus intravenous administration of aziridinylbenzoquinone, BCNU, and cisplatin in dogs.
Wright KC; Stephens LC; Wallace S; Savaraj N; Feun LG
Chemotherapy; 1987; 33(6):437-44. PubMed ID: 3428010
[TBL] [Abstract][Full Text] [Related]
16. Phase I evaluation and pharmacokinetics of aziridinylbenzoquinone using a weekly intravenous schedule.
Schilcher RB; Young JD; Leichman LP; Haas CD; Baker LH
Cancer Res; 1983 Aug; 43(8):3907-11. PubMed ID: 6683127
[TBL] [Abstract][Full Text] [Related]
17. Phase II clinical evaluation of AZQ in colorectal cancer.
Bedikian AY; Stroehlein JR; Karlin DA; Korinek J; Bodey GP
Am J Clin Oncol; 1982 Oct; 5(5):535-7. PubMed ID: 7180831
[TBL] [Abstract][Full Text] [Related]
18. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
Budman DR; Forastiere A; Perloff M; Perry M; Aisner J; Weinberg V; Wood W
Cancer Treat Rep; 1982 Oct; 66(10):1875-6. PubMed ID: 7127327
[No Abstract] [Full Text] [Related]
19. Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma.
Chahinian AP; Norton L; Holland JF; Szrajer L; Hart RD
Cancer Res; 1984 Apr; 44(4):1688-92. PubMed ID: 6423278
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]